日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Transcriptional Heterogeneity Overcomes Super-Enhancer Disrupting Drug Combinations in Multiple Myeloma

转录异质性克服了多发性骨髓瘤中超级增强子破坏药物组合的问题

Seth J Welsh #, Benjamin G Barwick #, Erin W Meermeier, Daniel L Riggs, Chang-Xin Shi, Yuan Xiao Zhu, Meaghen E Sharik, Megan T Du, Leslie D Abrego Rocha, Victoria M Garbitt, Caleb K Stein, Joachim L Petit, Nathalie Meurice, Yuliza Tafoya Alvarado, Rodrigo Fonseca, Kennedi T Todd, Sochilt Brown, Zac

Tumor burden limits bispecific antibody efficacy through T cell exhaustion averted by concurrent cytotoxic therapy

肿瘤负担限制了双特异性抗体的疗效,因为同时进行的细胞毒疗法可避免 T 细胞耗竭

Erin W Meermeier, Seth J Welsh, Meaghen E Sharik, Megan T Du, Victoria M Garbitt, Daniel L Riggs, Chang-Xin Shi, Caleb K Stein, Marco Bergsagel, Bryant Chau, Matthew L Wheeler, Natalie Bezman, Feng Wang, Pavel Strop, P Leif Bergsagel, Marta Chesi

Monosomic loss of MIR15A/MIR16-1 is a driver of multiple myeloma proliferation and disease progression

MIR15A/MIR16-1单体缺失是多发性骨髓瘤增殖和疾病进展的驱动因素。

Chesi, Marta; Stein, Caleb K; Garbitt, Victoria M; Sharik, Meaghen E; Asmann, Yan W; Bergsagel, Matteo; Riggs, Daniel L; Welsh, Seth J; Meermeier, Erin W; Kumar, Shaji K; Braggio, Esteban; Bergsagel, P Leif

Microbiota-driven interleukin-17-producing cells and eosinophils synergize to accelerate multiple myeloma progression

微生物群驱动的白细胞介素-17产生细胞和嗜酸性粒细胞协同作用,加速多发性骨髓瘤的进展。

Arianna Calcinotto ,Arianna Brevi ,Marta Chesi ,Roberto Ferrarese ,Laura Garcia Perez ,Matteo Grioni ,Shaji Kumar ,Victoria M Garbitt ,Meaghen E Sharik ,Kimberly J Henderson ,Giovanni Tonon ,Michio Tomura ,Yoshihiro Miwa ,Enric Esplugues ,Richard A Flavell ,Samuel Huber ,Filippo Canducci ,Vincent S Rajkumar ,P Leif Bergsagel ,Matteo Bellone

IAP antagonists induce anti-tumor immunity in multiple myeloma

IAP 拮抗剂诱导多发性骨髓瘤的抗肿瘤免疫

Marta Chesi, Noweeda N Mirza, Victoria M Garbitt, Meaghen E Sharik, Amylou C Dueck, Yan W Asmann, Ilseyar Akhmetzyanova, Heidi E Kosiorek, Arianna Calcinotto, Daniel L Riggs, Niamh Keane, Gregory J Ahmann, Kevin M Morrison, Rafael Fonseca, Martha Q Lacy, David Dingli, Shaji K Kumar, Sikander Ailawad

Genome-wide studies in multiple myeloma identify XPO1/CRM1 as a critical target validated using the selective nuclear export inhibitor KPT-276

多发性骨髓瘤的全基因组研究确定 XPO1/CRM1 是使用选择性核输出抑制剂 KPT-276 验证的关键靶点

J Schmidt, E Braggio, K M Kortuem, J B Egan, Y X Zhu, C S Xin, R E Tiedemann, S E Palmer, V M Garbitt, D McCauley, M Kauffman, S Shacham, M Chesi, P L Bergsagel, A K Stewart

Drug response in a genetically engineered mouse model of multiple myeloma is predictive of clinical efficacy

在基因工程改造的多发性骨髓瘤小鼠模型中,药物反应可预测临床疗效。

Chesi, Marta; Matthews, Geoffrey M; Garbitt, Victoria M; Palmer, Stephen E; Shortt, Jake; Lefebure, Marcus; Stewart, A Keith; Johnstone, Ricky W; Bergsagel, P Leif

Clonal competition with alternating dominance in multiple myeloma

多发性骨髓瘤中的克隆竞争与交替显性

Jonathan J Keats, Marta Chesi, Jan B Egan, Victoria M Garbitt, Stephen E Palmer, Esteban Braggio, Scott Van Wier, Patrick R Blackburn, Angela S Baker, Angela Dispenzieri, Shaji Kumar, S Vincent Rajkumar, John D Carpten, Michael Barrett, Rafael Fonseca, A Keith Stewart, P Leif Bergsagel

SIK1 couples LKB1 to p53-dependent anoikis and suppresses metastasis

SIK1 将 LKB1 与 p53 依赖性失巢凋亡偶联,并抑制转移

Cheng, Hailing; Liu, Pixu; Wang, Zhigang C; Zou, Lihua; Santiago, Stephanie; Garbitt, Victoria; Gjoerup, Ole V; Iglehart, J Dirk; Miron, Alexander; Richardson, Andrea L; Hahn, William C; Zhao, Jean J

Nuclear entry and CRM1-dependent nuclear export of the Rous sarcoma virus Gag polyprotein

劳氏肉瘤病毒Gag多聚蛋白的核内进入和CRM1依赖的核输出

Scheifele, Lisa Z; Garbitt, Rachel A; Rhoads, Jonathan D; Parent, Leslie J